Lipoprotein(a) as Part of the Diagnosis of Clinical Familial Hypercholesterolemia

被引:11
|
作者
Langsted, Anne [1 ,2 ,3 ]
Nordestgaard, Borge G. [1 ,2 ,3 ]
机构
[1] Copenhagen Univ Hosp, Dept Clin Biochem, Herlev & Gentofte Hosp, Borgmester Ib Juuls Vej 1, DK-2730 Herlev, Denmark
[2] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Copenhagen Gen Populat Study, Borgmester Ib Juuls Vej 1, DK-2730 Herlev, Denmark
[3] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark
关键词
Kringle IV type 2; Atherosclerotic cardiovascular disease; LDL cholesterol; Heterozygous FH; LDL receptor; CORONARY-HEART-DISEASE; ELEVATED LIPOPROTEIN(A); CARDIOVASCULAR-DISEASE; RISK-FACTOR; STATEMENT; GUIDANCE; EVENTS; BURDEN; UPDATE;
D O I
10.1007/s11883-022-01002-0
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Purpose of Review Individuals with familial hypercholesterolemia have very high risk of cardiovascular disease due to lifelong elevations in LDL cholesterol. Elevated lipoprotein(a) is a risk factor for cardiovascular diseases such as myocardial infarction and aortic valve stenosis. It has been proposed to include elevated lipoprotein(a) in the diagnosis of clinical familial hypercholesterolemia. Recent Findings Lipoprotein(a) is co-measured in LDL cholesterol, and up to one-quarter of all diagnoses of clinical familial hypercholesterolemia are due to high levels of lipoprotein(a). Further, individuals with both familial hypercholesterolemia and elevated lipoprotein(a) have an extremely high risk of myocardial infarction. We discuss the background for familial hypercholesterolemia and elevated lipoprotein(a) as risk factors for cardiovascular disease and the consequences of the fact that LDL cholesterol measurements/calculations include the cholesterol present in lipoprotein(a). Finally, we discuss the potential of including lipoprotein(a) as part of the diagnosis of familial hypercholesterolemia and in consequence possible treatments.
引用
收藏
页码:289 / 296
页数:8
相关论文
共 50 条
  • [31] Clinical and genetic diagnosis of familial hypercholesterolemia in young subjects in Spain
    Real, JT
    Puig, O
    Chaves, J
    GarciaSogo, M
    Priego, A
    Ascaso, JF
    Carmena, R
    Armengod, M
    ATHEROSCLEROSIS, 1997, 130 : 120 - 120
  • [32] Clinical criteria versus DNA diagnosis in heterozygous familial hypercholesterolemia - Is molecular diagnosis superior to clinical diagnosis?
    Schuster, H
    Luft, FC
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (03) : 331 - 332
  • [33] POSTMORTEM DIAGNOSIS OF FAMILIAL HYPERCHOLESTEROLEMIA
    LEADBEATTER, S
    STANSBIE, D
    BRITISH MEDICAL JOURNAL, 1984, 289 (6459): : 1656 - 1656
  • [34] PHENOTYPIC HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA AND ELEVATED LIPOPROTEIN (A)
    Vani, Anish
    Hurta, Vanessa
    Underberg, James
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 42 - 43
  • [35] Familial Hypercholesterolemia and Lipoprotein(a): Two Partners in Crime?
    Rodrigo Alonso
    Rosa Argüeso
    Pilar Álvarez-Baños
    Ovidio Muñiz-Grijalvo
    Jose Luis Diaz-Diaz
    Pedro Mata
    Current Atherosclerosis Reports, 2022, 24 : 427 - 434
  • [36] SERUM LIPOPROTEIN AND LDL PATHWAY IN FAMILIAL HYPERCHOLESTEROLEMIA
    MABUCHI, H
    JAPANESE JOURNAL OF MEDICINE, 1981, 20 (02) : 140 - 140
  • [37] Familial Hypercholesterolemia and Lipoprotein(a): Two Partners in Crime?
    Alonso, Rodrigo
    Argueso, Rosa
    Alvarez-Banos, Pilar
    Muniz-Grijalvo, Ovidio
    Diaz-Diaz, Jose Luis
    Mata, Pedro
    CURRENT ATHEROSCLEROSIS REPORTS, 2022, 24 (06) : 427 - 434
  • [38] INCREASED LIPOPROTEIN(A) LEVELS IN CHILDREN WITH FAMILIAL HYPERCHOLESTEROLEMIA
    WIDHALM, K
    GENSER, D
    LANCET, 1988, 2 (8622): : 1262 - 1262
  • [39] ELEVATED LEVELS OF LIPOPROTEIN (A) IN CHILDREN WITH FAMILIAL HYPERCHOLESTEROLEMIA
    WIDHALM, K
    GENSER, D
    WIENER KLINISCHE WOCHENSCHRIFT, 1994, 106 (07) : 197 - 200
  • [40] LIPOPROTEIN APHERESIS IN THE TREATMENT OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    TERUEL, JL
    LASUNCION, MA
    LIANO, F
    HERRERA, E
    ORTUNO, J
    NEFROLOGIA, 1992, 12 (05): : 399 - 403